Test Price
150 AED✅ Home Collection Available
Varicella Zoster Virus (VZV) Antibody IgM Test in UAE | 150 AED | DHA Licensed Laboratory
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited processing, ensuring reliable detection of acute Varicella‑Zoster infection.
Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily from 8 AM to 11 PM.
Clinical Guidance: Telephonic post‑test result interpretation by a DHA‑licensed General Practitioner to discuss next steps.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
The VZV IgM test detects recent or reactivated Varicella Zoster virus infection with high precision. This assay is essential for managing at‑risk groups including pregnant women, immunocompromised patients, and adults presenting with severe or atypical rash. All testing is performed at DNA Labs UAE under DHA Facility License No. 1143, ensuring full regulatory compliance and data protection in accordance with UAE Federal Law.
Test Overview & Methodology
The Varicella Zoster Virus (VZV) IgM antibody test employs Chemiluminescent Immunoassay (CLIA) technology—a fully automated, high‑throughput method that delivers superior sensitivity and specificity compared to traditional manual ELISA. CLIA reduces cross‑reactivity with other herpesviruses and provides rapid, reproducible results. A positive IgM result indicates recent primary infection or viral reactivation, while a negative result helps rule out acute disease when clinical suspicion is low.
This serology test is performed on a routine venous blood sample (serum or plasma). No special preparation is required. Results are typically available within 24 hours of sample collection, enabling timely clinical decision‑making for antiviral therapy, isolation protocols, or prophylactic measures in exposed contacts.
| Feature | Our VZV IgM (CLIA) | Alternative (ELISA) |
|---|---|---|
| Methodology | Chemiluminescent Immunoassay (CLIA) – fully automated, high specificity | Manual ELISA – variable sensitivity |
| Diagnostic Precision | 99.9% Sensitivity / 99.8% Specificity | ~95% Sensitivity / 97% Specificity |
| Turnaround Time | Same‑day reporting (sample by 9 AM Mon) | 2–5 working days |
Physician Insight & Safety Protocols
“As a DHA‑licensed General Practitioner, I advise that a positive VZV IgM result should always be interpreted alongside the patient's clinical history and physical examination findings. False‑positive results can occur, particularly in the setting of other herpesvirus infections or autoimmune conditions. A comprehensive clinical assessment is essential before initiating any treatment or making public health decisions.”
— Dr. Ajay Singh, General Practitioner (DHA Registration ID: 36234132)
Advisory: Medication & Clinical Safety
⚠️ Important Precautions
Do not alter or discontinue any prescribed antiviral, immunosuppressant, or other medication without explicit guidance from your treating physician. This laboratory test is an adjunct to clinical evaluation, not a replacement. Abrupt self‑directed changes to your medication regimen may lead to serious health complications. Always consult your healthcare provider before making any treatment decisions.
Exclusion Criteria & Emergency Red Flags
Do not proceed with home collection if you experience any of the following:
- Widespread blistering rash with bleeding or skin breakdown
- Fever exceeding 39°C that does not respond to antipyretics
- Altered consciousness, seizures, or stiff neck
- Known severe immunocompromise without prior clearance from your specialist
Emergency Red Flags: Seek immediate emergency care if you develop severe headache, confusion, difficulty breathing, chest pain, or vision changes. These symptoms may indicate viral dissemination or complications such as pneumonia or encephalitis requiring urgent medical intervention.
Patient FAQ & Clinical Guidance
1. What does a positive VZV IgM result mean, and how should I act on it?
A positive VZV IgM generally indicates recent or active varicella‑zoster infection. This finding requires immediate clinical correlation by your physician. Confirmatory testing with PCR or paired IgG serology may be recommended to exclude cross‑reactivity with other herpesviruses. If you are pregnant or immunocompromised, contact your healthcare provider urgently to discuss antiviral therapy or immunoglobulin prophylaxis.
2. How soon after exposure can VZV IgM be detected, and when is the optimal time to test?
VZV‑specific IgM antibodies typically become detectable 3–5 days after rash onset, or 7–14 days following exposure. For highest diagnostic yield, blood collection should occur on day 3–5 of the rash. Testing too early or too late may produce false‑negative results. If initial IgM is negative but clinical suspicion remains high, a follow‑up IgG test after 2–3 weeks can help identify seroconversion.
3. How long do VZV IgM antibodies persist after infection?
IgM levels rise rapidly after rash onset and typically decline over 4–8 weeks. Persistent IgM positivity beyond 8 weeks is uncommon and may warrant evaluation by an infectious disease specialist to rule out chronic reactivation or a false‑positive result. Serial antibody testing can clarify the clinical picture when results are equivocal.
4. Can I take the VZV IgM test if I am currently on antiviral medication?
Yes, the test can be performed while on antiviral therapy. However, antivirals may suppress viral replication and potentially affect antibody kinetics. Inform your physician about all medications you are taking so that results can be interpreted accurately. Do not stop or adjust your medication without medical advice.
UAE Regulatory & Data Privacy Adherence
Data Protection & Health Information Security: DNA Labs UAE operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data is encrypted, access‑controlled, and processed exclusively within UAE jurisdiction.
Clinical Safety & Patient Consent: All diagnostic procedures and patient interactions adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring informed consent, clinical accountability, and the highest standards of patient safety.
Licensed & Regulated: This test is performed under DHA Facility License No. 1143 at DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. Our laboratory is ISO 9001:2015 accredited and follows all mandatory UAE healthcare regulations.
Clinical & Logistical Metadata
| Test Name | Varicella Zoster Virus (VZV) Antibody IgM |
| Price (AED) | 150 AED |
| Turnaround Time | Same‑day reporting (sample received by 9 AM Monday – Friday) |
| Sample Type / Matrix | Serum or Plasma (standard venous blood draw) |
| Methodology Used | Chemiluminescent Immunoassay (CLIA) |
| ICD-10-CM Code | B01.9 |
| LOINC Code | 16011-5 |
| DHA Facility License & Laboratory Address | License No. 1143 – DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians